InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
22%
T+90 mean return
-8.1%
Across 18 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Hopper Jonathan Mark, Chief Medical Officer. Officer active across 1 company, notably Vericel Corp. In total, 27 filings have been logged. Split: 0 buy · 2 sells. History available since 30 June 2021. The latest transaction was filed on 2 April 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations27 total
5,000 sharesCommon StockSEC:0001140361-26-026930:0
5,000 sharesCommon StockSEC:0001140361-26-026930:1
5,000 sharesCommon StockSEC:0001140361-26-026930:2
5,000 sharesCommon StockSEC:0001140361-26-026930:3
3,472 shares@ US$10.950.0020% mcap16.8% of flowCommon StockSEC:0001140361-26-013334:0
3,472 shares@ US$10.950.0020% mcap16.8% of flowCommon StockSEC:0001140361-26-013334
10,000 shares@ US$18.0022.3% of flowCommon StockSEC:0001140361-25-007179:0
1,500 sharesCommon StockSEC:0001140361-25-006086:0
3,000 sharesCommon StockSEC:0001140361-25-005256:0
10,000 shares@ US$16.6620.3% of flowCommon StockSEC:0001140361-24-048294:0
10,000 shares@ US$10.9512.8% of flowCommon StockSEC:0001140361-24-040225:0
10,000 shares@ US$10.9513.0% of flowCommon StockSEC:0001140361-24-027027:0
3,000 shares0Common StockSEC:0001140361-24-009025:0
1,625 shares0Common StockSEC:0001140361-24-007424:0
5,000 shares@ US$10.956.5% of flowCommon StockSEC:0001140361-23-054439:0
2,325 shares0Common StockSEC:0001127602-23-006586:0
1,625 shares0Common StockSEC:0001127602-23-005118:0
650 shares0Common StockSEC:0001127602-23-003988:0
10,000 shares@ US$10.950.0058% mcap49.9% of flowCommon StockSEC:0001593968-22-000613:0
1,750 shares0Common StockSEC:0001593968-22-000517:0
1,625 shares0Common StockSEC:0001593968-22-000470:0
650 shares0Common StockSEC:0001593968-22-000423:0
650 shares0Common StockSEC:0001593968-22-000423
1,000 shares@ US$10.951.3% of flowCommon StockSEC:0001593968-21-002569
1,000 shares@ US$10.950.0006% mcap5.0% of flowCommon StockSEC:0001593968-21-002569:0
25 of 27 declarations
About Hopper Jonathan Mark
Jonathan Mark Hopper serves as Chief Medical Officer at Vericel Corp. He is responsible for the medical leadership of the company, overseeing research and development initiatives and ensuring compliance with medical standards.
